About Kraig Higginson
Form D filings for Aspire BioPharma in 2023 list Kraig Higginson as president and CEO, director.
Kraig Higginson first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Kraig Higginson in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Kraig Higginson works with at each company, as listed on that company's latest Form D.
Aspire BioPharma, Inc. · Form D, Nov 1, 2023
ES
Ernest Scheidemann
Executive officer and director
RP
Rodrick Prat
Director
SQ
Stephen Quesenberry
Executive officer and director
EK
Edward Kimball
Director